Assessing progression or regression of CAD: the role of perfusion imaging.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Cardiac taurine and principal amino acids in right and left ventricles of patients with either aortic valve stenosis or coronary artery disease: the importance of diabetes and gender.SpringerPlus · 2014
   Article
2. Evaluating the prognostic value of positron-emission tomography myocardial perfusion imaging using automated software to calculate perfusion defect size.Clinical cardiology · 2012
   Article
3. Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weight.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2012
   Article
4. Partial volume correction incorporating Rb-82 positron range for quantitative myocardial perfusion PET based on systolic-diastolic activity ratios and phantom measurements.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2011
   Article
5. Shifted helical computed tomography to optimize cardiac positron emission tomography-computed tomography coregistration: quantitative improvement and limitations.Molecular imaging · 2010
   Article
6. Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus.European journal of nuclear medicine and molecular imaging · 2009
   Article
7. Is it possible for myocardial perfusion imaging to avoid missing any patients with high-risk coronary disease?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2007
   Article
8. Reply.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2006
   Article
9. Noninvasive stress testing of myocardial perfusion defects: head-to-head comparison of thallium-201 SPECT to MRI perfusion.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
   Article
10. Larger perfusion defects with exercise compared with dipyridamole SPECT (exercise-dipyridamole mismatch) may reflect differences in epicardial and microvascular coronary dysfunction: when the stressor matters.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Article
11. "Mismatch" in regional myocardial perfusion defects during exercise and pharmacologic vasodilation: a noninvasive marker of epicardial vasomotor dysfunction?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Article
12. Diagnostic value of PET-measured heterogeneity in myocardial blood flows during cold pressor testing for the identification of coronary vasomotor dysfunction.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as